Karger Publishers, Pathophysiology of Haemostasis and Thrombosis, 3(21), p. 169-174, 1991
DOI: 10.1159/000216222
Full text: Unavailable
In order to verify if H<sub>2</sub>O<sub>2</sub> affects platelet function, platelet-rich plasma and human washed platelets were incubated with subthreshold concentrations (STC) of collagen or arachidonic acid or ADP and/or with 75–150 μ<i>M</i> H<sub>2</sub>O<sub>2</sub>. While H<sub>2</sub>O<sub>2</sub> alone did not affect platelet aggregation, it amplified platelet aggregation response in samples stimulated with STC of arachidonic acid and collagen but not in samples stimulated with STC of ADP. When platelets were preventively treated with aspirin, a cyclooxygenase inhibitor, the platelet activation by H<sub>2</sub>O<sub>2</sub> was not observed. Thromboxane A<sub>2</sub> (TxA<sub>2</sub>) was not produced by human washed platelets stimulated with STC of arachidonic acid, collagen or by H<sub>2</sub>O<sub>2</sub> alone. On the contrary, when STC of agonists were tested on platelets supplemented with H<sub>2</sub>O<sub>2</sub> an evident TxA<sub>2</sub> production was seen. This effect was prevented by aspirin pretreatment or by the addition of catalase, an enzyme which destroys H<sub>2</sub>O<sub>2</sub>. This study suggests that H<sub>2</sub>O<sub>2</sub> triggers the activation of platelets exposed to STC of collagen and arachidonic acid, via the cyclooxygenase pathway.